B
Biocytogen
Biotech & Life Sciences · Wakefield, United States · Founded 2009 · IPO 2022 Unicorn
Investors
7 investors on Biocytogen's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Global footprint
Where Biocytogen has talent and traffic
team presence
across markets
Patent intelligence
$63M patent portfolio · 276 active families
Where Biocytogen concentrates vs peers
Each axis is a top-10 topic across Biocytogen and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Biocytogen
An AI-synthesized read of the highest-engagement posts about Biocytogen on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biocytogen on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.